Clin2
NCT07478484Possibly a fitRecruiting

Different ways to take antibiotics for resistant infections

Ceftazidime-avibactamAztreonamGram-negative Bacterial InfectionMetallo-β-lactamase-producingCarbapenem-resistant

Part of Infections clinical trials.

This trial tests two different schedules of a combination of antibiotics (ceftazidime-avibactam plus aztreonam) for people with serious infections caused by bacteria that are hard to treat. It aims to find the best way to give these medicines.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
144 people
Ages
18 years to 100 years
Study type
Interventional

Who can take part

  • You have a serious infection in your belly, lungs, bladder, or blood.
  • Your infection is caused by a specific type of bacteria that is resistant to many antibiotics.
  • You are already being treated with the combination of ceftazidime-avibactam and aztreonam.
  • You are 18 years or older.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07494981Not yet recruiting
Precision Antibiotic Dosing in Older Adults

This trial tests a personalized way of giving a strong antibiotic (ceftazidime-avibactam) to older adults. Doctors adjust the dose based on your own body's handling of the drug, aiming to make treatment safer and more effective.

NCT05979545Recruiting· Phase 4
Early treatment with ceftazidime-avibactam for serious infections

This study tests an antibiotic called ceftazidime-avibactam for people with serious infections like bloodstream infections or pneumonia that started in the hospital or from a breathing machine. It aims to start treatment quickly after identifying the bacteria.

Kuala Lumpur
NCT07063095Recruiting· Phase 3
Testing two antibiotics combined for serious bacterial infections

This study tests whether combining two antibiotics (ceftazidime and fosfomycin) works better than ceftazidime alone for hospitalized adults with serious bacterial infections. If you have a severe infection thought to be caused by Gram-negative bacteria, this trial may offer a new treatment option.

Geneva, Canton of Geneva
NCT07176247Enrolling by invitation
Study of aztreonam-avibactam for drug-resistant infections

This trial studies a combination antibiotic called aztreonam-avibactam for treating infections caused by hard-to-treat bacteria, especially those that produce certain enzymes (MBLs). It aims to see how well this medicine works in hospital patients.

Paris
NCT06210542Not yet recruiting
Precise dosing of a strong antibiotic for ICU patients with resistant infections

This study tests a precise dosing approach for the antibiotic ceftazidime-avibactam to treat serious infections in ICU patients. It aims to help people with hard-to-treat bacteria that are resistant to many other antibiotics.

NCT07268560Recruiting
Testing a new antibiotic combination for certain drug-resistant infections

This trial is checking how well a combination of two antibiotics, aztreonam and avibactam, works in patients who have a specific type of drug-resistant bacterial infection in the belly or lungs. It aims to offer a new treatment option for infections that are hard to cure.

Nanchang, Jiangxi

Hear when a new Ceftazidime-avibactam trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.